BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 34332622)

  • 1. Infection prevention and control (IPC) implementation in low-resource settings: a qualitative analysis.
    Tomczyk S; Storr J; Kilpatrick C; Allegranzi B
    Antimicrob Resist Infect Control; 2021 Jul; 10(1):113. PubMed ID: 34332622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of the WHO core components of an infection prevention and control programme in two sub-saharan African acute health-care facilities: a mixed methods study.
    Wood R; Tembele W; Hema A; Somé A; Kinganda-Lusamaki E; Basilubo C; Lumembe R; Alama N; Mbunsu G; Zongo A; Ahuka S; Muyembe JJ; Leendertz F; Eckmanns T; Schubert G; Kagoné T; Makiala S; Tomczyk S
    Antimicrob Resist Infect Control; 2024 Jan; 13(1):4. PubMed ID: 38221629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A national survey on the implementation of key infection prevention and control structures in German hospitals: results from 736 hospitals conducting the WHO Infection Prevention and Control Assessment Framework (IPCAF).
    Aghdassi SJS; Hansen S; Bischoff P; Behnke M; Gastmeier P
    Antimicrob Resist Infect Control; 2019; 8():73. PubMed ID: 31080588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of the infection prevention and control core components at the national level: a global situational analysis.
    Tartari E; Tomczyk S; Pires D; Zayed B; Coutinho Rehse AP; Kariyo P; Stempliuk V; Zingg W; Pittet D; Allegranzi B
    J Hosp Infect; 2021 Feb; 108():94-103. PubMed ID: 33271215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation research for the prevention of antimicrobial resistance and healthcare-associated infections; 2017 Geneva infection prevention and control (IPC)-think tank (part 1).
    Zingg W; Storr J; Park BJ; Ahmad R; Tarrant C; Castro-Sanchez E; Tomczyk S; Kilpatrick C; Allegranzi B; Cardo D; Pittet D;
    Antimicrob Resist Infect Control; 2019; 8():87. PubMed ID: 31161034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers and facilitators to infection prevention and control in Dutch psychiatric institutions: a theory-informed qualitative study.
    Houben F; van Hensbergen M; den Heijer CDJ; Dukers-Muijrers NHTM; Hoebe CJPA
    BMC Infect Dis; 2022 Mar; 22(1):243. PubMed ID: 35277134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the implementation of WHO infection prevention and control core components in Turkish health care facilities: results from a WHO infection prevention and control assessment framework (IPCAF)-based survey.
    Azak E; Sertcelik A; Ersoz G; Celebi G; Eser F; Batirel A; Cag Y; Ture Z; Ozturk Engin D; Yetkin MA; Kaygusuz S; Candevir A; Tartari E; Rello J; Alp E;
    Antimicrob Resist Infect Control; 2023 Feb; 12(1):11. PubMed ID: 36782267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Core components of infection prevention and control programs at the facility level in Georgia: key challenges and opportunities.
    Deryabina A; Lyman M; Yee D; Gelieshvilli M; Sanodze L; Madzgarashvili L; Weiss J; Kilpatrick C; Rabkin M; Skaggs B; Kolwaite A
    Antimicrob Resist Infect Control; 2021 Feb; 10(1):39. PubMed ID: 33627194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing of the WHO Infection Prevention and Control Assessment Framework at acute healthcare facility level.
    Tomczyk S; Aghdassi S; Storr J; Hansen S; Stewardson AJ; Bischoff P; Gastmeier P; Allegranzi B
    J Hosp Infect; 2020 May; 105(1):83-90. PubMed ID: 31870887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparedness of tertiary care hospitals to implement the national TB infection prevention and control guidelines in Bangladesh: A qualitative exploration.
    Islam MS; Tarannum S; Banu S; Chowdhury KIA; Nazneen A; Chughtai AA; Seale H
    PLoS One; 2022; 17(2):e0263115. PubMed ID: 35113905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection prevention and control in tertiary care hospitals of Bangladesh: results from WHO infection prevention and control assessment framework (IPCAF).
    Harun MGD; Anwar MMU; Sumon SA; Hassan MZ; Haque T; Mah-E-Muneer S; Rahman A; Abdullah SAHM; Islam MS; Styczynski AR; Kaydos-Daniels SC
    Antimicrob Resist Infect Control; 2022 Oct; 11(1):125. PubMed ID: 36203207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating infection prevention and control programs in Austrian acute care hospitals using the WHO Infection Prevention and Control Assessment Framework.
    Aghdassi SJS; Grisold A; Wechsler-Fördös A; Hansen S; Bischoff P; Behnke M; Gastmeier P
    Antimicrob Resist Infect Control; 2020 Jun; 9(1):92. PubMed ID: 32571434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers and facilitators to infection prevention and control in Dutch residential care facilities for people with intellectual and developmental disabilities: A theory-informed qualitative study.
    Houben F; van Hensbergen M; Den Heijer CDJ; Dukers-Muijrers NHTM; Hoebe CJPA
    PLoS One; 2021; 16(10):e0258701. PubMed ID: 34714846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale and guidance for strengthening infection prevention and control measures and antimicrobial stewardship programs in Bangladesh: a study protocol.
    Harun MGD; Anwar MMU; Sumon SA; Hassan MZ; Mohona TM; Rahman A; Abdullah SAHM; Islam MS; Kaydos-Daniels SC; Styczynski AR
    BMC Health Serv Res; 2022 Oct; 22(1):1239. PubMed ID: 36207710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoting health workers' ownership of infection prevention and control: using Normalization Process Theory as an interpretive framework.
    Gould DJ; Hale R; Waters E; Allen D
    J Hosp Infect; 2016 Dec; 94(4):373-380. PubMed ID: 27810221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of infection prevention and control committees in Lesotho: A qualitative study.
    Mugomeri E
    Am J Infect Control; 2018 Mar; 46(3):e13-e17. PubMed ID: 29326003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The first WHO global survey on infection prevention and control in health-care facilities.
    Tomczyk S; Twyman A; de Kraker MEA; Coutinho Rehse AP; Tartari E; Toledo JP; Cassini A; Pittet D; Allegranzi B
    Lancet Infect Dis; 2022 Jun; 22(6):845-856. PubMed ID: 35202599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection prevention and control in Dutch general practices before and during the COVID-19 pandemic and its implications for pandemic preparedness and seasonal respiratory epidemics: a qualitative study on lessons learned.
    Houben F; den Heijer CDJ; Dukers-Muijrers NHTM; de Bont EGPM; Volbeda HT; Hoebe CJPA
    BMC Prim Care; 2024 Jun; 25(1):222. PubMed ID: 38902628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is needed to sustain improvements in hospital practices post-COVID-19? a qualitative study of interprofessional dissonance in hospital infection prevention and control.
    Gilbert GL; Kerridge I
    BMC Health Serv Res; 2022 Apr; 22(1):504. PubMed ID: 35421985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioural determinants shaping infection prevention and control behaviour among healthcare workers in Dutch general practices: a qualitative study reflecting on pre-, during and post-COVID-19 pandemic.
    Houben F; den Heijer CD; van Hensbergen M; Dukers-Muijrers NH; de Bont EG; Hoebe CJ
    BMC Prim Care; 2024 Feb; 25(1):72. PubMed ID: 38418938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.